The DOI matches its Crossref record; 188 of the 189 references it cites were found in a registry or an index.
11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2021
Abstract
The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc21-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc21-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Since the design of the FIGARO-DKD and FIDELIO-DKD studies, SGLT-2 inhibitors have emerged as therapeutic options for patients with CKD and type 2 diabetes.30”
From Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis (2022) · cites this paper as [30]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607141 · Cited by 6,900
Flagged first, then by citations
1 of the 189 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- United States Renal Data System, 2016, Annual Data Report: Epidemiology of Kidney Disease in the United States
- Nadkarni, 2017, Acute kidney injury in patients on SGLT2 inhibitors: a propensity-matched analysis, 1479
- Boulton AJM . The Diabetic Foot, 2000. South Dartmouth, MA, MDText.com, Inc. Accessed 11 August 2020. Available from http://www.ncbi.nlm.nih.gov/books/NBK409609/
Cited by
Sorted by citations
Items 301–397 of 397
Yin, Y., Huang, Z., Li, Y., Chen, Y., Cheng, K., Deng, H., Lv, W., Wang, Y., Shen, X., Zhao, L., et al. (2025) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2025.103259 · Cited by 1
Su, K.-X., Jiang, S.-Y., Pang, C.-F., Yang, F., Tang, Y.-Q., Li, X.-G., He, W.-F., & Li, R. (2026) · World Journal of Cardiology · doi:10.4330/wjc.v18.i1.112857 · Cited by 1
Biochemical–Cellular crosstalk in diabetes: exploring pathways driving microvascular complications
Mishra, A., Vadher, P., Baldiwala, T., & Shah, H. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11474-x · Cited by 1
La tungiasis empeora el pronóstico del pie diabético
Carretero-Anibarro, E., & Peñacoba-Masa, A. (2021) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2021.09.010 · Cited by 1
Julian, G. S., Pititto, L. M. A., Miresashvili, N., Honoré, J. B., Coelho, R. C. L. A., & Campos, D. (2021) · Journal of Medical Economics · doi:10.1080/13696998.2021.1963572 · Cited by 2
Biomarkers of dyslipidemia in patients with diabetic foot
Vujčić, S., Stefanović, T., Zeljković, A., Mihajlović, M., & Vekić, J. (2022) · Arhiv za farmaciju · doi:10.5937/arhfarm72-36296 · Cited by 1
Neuropathy in Type 1 and Type 2 Diabetes
Akıncı, G., Nowacek, D. G., & Callaghan, B. C. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-15613-7_4 · Cited by 1
Detection, management, and prevention of diabetes-related foot disease in the Australian context
McNeil, S. E., Waller, K., Lorenzo, Y. S. P., Mateevici, O. C., Telianidis, S., Qi, S. D., Churilov, I., MacIsaac, R. J., & Galligan, A. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i7.942 · Cited by 1
Siddiqui, A. H., Chiragh, S., & Malik, M. (2023) · BIOMEDICA · doi:10.24911/biomedica/5-841 · Cited by 1
Masuda, H., Iwashima, F., Ishiyama, D., Nakajima, H., Kimura, Y., Otobe, Y., Suzuki, M., Koyama, S., Tanaka, S., Kojima, I., et al. (2023) · Current Diabetes Reviews · doi:10.2174/0115733998269490231106190128 · Cited by 1
Ali, A. M., Cobran, E. K., & Young, H. N. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01388-5 · Cited by 1
Diabetic kidney disease in rural Australia: prevention, management, treatment and way forward
Ross, A. G., Mondal, U. K., Anyasodor, A. E., Mahmood, S., Astawesegn, F. H., Huda, M. M., Thapa, S., Aychiluhm, S. B., Giri, S., Rahman, M. F., et al. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1561566 · Cited by 1
Pie diabetico y estilo de vida: Reporte de Caso
García, D. A. R., Flores, R. L., & Ordoñez, F. C. (2021) · Revista de la Facultad de Medicina Humana · doi:10.25176/rfmh.v22i1.4137 · Cited by 1
Day-by-Day Home Blood Pressure Monitoring as a Biomarker in Diabetes
Suzuki, D., Hoshide, S., & Kario, K. (2022) · Biomarkers in disease · doi:10.1007/978-3-030-81303-1_36-1 · Cited by 1
Day-by-Day Home Blood Pressure Monitoring as a Biomarker in Diabetes
Suzuki, D., Hoshide, S., & Kario, K. (2022) · Biomarkers in disease · doi:10.1007/978-3-031-08014-2_36 · Cited by 1
A STUDY OF LEVELS OF hs-CRP AND LIPID PROFILE IN PATIENTS WITH DIABETIC NEPHROPATHY
Muniyal, H., Jheetay, S., & Mishra, A. (2022) · Journal of Pharmaceutical Negative Results · doi:10.47750/pnr.2022.13.s01.252 · Cited by 1
Atherosclerotic Cardiovascular Disease Prevention in the Older Adult: Part 2
Murphy, E., Cooney, M. T., & McEvoy, J. W. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-16594-8_2 · Cited by 1
Rosida, S. R., Lestyani, L., & Sudaryanto, S. (2023) · J Abdimas Community Health · doi:10.30590/jach.v4n1.601 · Cited by 1
Diabetes Management in the United States
Shah, M. K., Khan, F. N., & Ali, M. K. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_19 · Cited by 1
van den Heuvel, T. R. A., Castañeda, J., Arrieta, A., & Cohen, O. (2023) · Diabetic Medicine · doi:10.1111/dme.15171 · Cited by 1
Kato, S., Kuwatsuka, Y., Ando, M., Tatematsu, Y., Nishibori, N., & Maruyama, S. (2023) · BMC Nephrology · doi:10.1186/s12882-023-03277-0 · Cited by 2
Nerve Block Research in Diabetic Foot Ulcers: Concerns and Suggestions [Response to Letter]
Wei, Q., & Dai, W. (2025) · Journal of Pain Research · doi:10.2147/jpr.s515063 · Cited by 1
CENTER BASED VERSES TELE-REHABILITATION FOR DIABETES MELLITUS
Waqqar, S. (2021) · The Rehabilitation Journal · doi:10.52567/trj.v5i01.54
Barvian, C. K., & Cipriano, G. C. (2021) · Journal of Pharmacy Practice · doi:10.1177/08971900211039707
Topics on combined problem of diabetes and periodontitis from epidemiological point of view
Sakamoto, D., & Bando, H. (2021) · MOJ Public Health · doi:10.15406/mojph.2021.10.00358
Features of chronic complications in latent autoimmune diabetes in adults
Tsaryk, I., & Pashkovska, N. V. (2021) · Clinical endocrinology and endocrine surgery · doi:10.30978/cees-2021-1-45 · Cited by 1
Diabetes and Kidney Disease: A Review of the Clinical Practice Guidelines
Aggarwal, N., Ali, S., & Navaneethan, S. D. (2022) · Springer eBooks · doi:10.1007/978-3-030-86020-2_2
Nobre, C. A., Rodrigues, C. E. M., Aragão, G. F., & Bezerra, M. M. (2022) · Amplla Editora eBooks · doi:10.51859/amplla.tis167.1122-6
Treatment of Diabetic Nephropathy Based on the Theory of “The Origin of Nature and Nurture”
徐, 丽. (2022) · Traditional Chinese Medicine · doi:10.12677/tcm.2022.112047
ALTERAÇÕES METABÓLICAS E DA COMPOSIÇÃO CORPORAL NA ESQUIZOFRENIA
Feitoza, A. Á. P., Aragão, G. F., & Macêdo, D. S. (2022) · Amplla Editora eBooks · doi:10.51859/amplla.tis167.1122-5
RISCO DE SARCOPENIA AVALIADO PELO SARC-CALF EM PACIENTES COM CÂNCER
do Nascimento, B. P., Rocha, J. A., Aragão, G. F., & Moreira-Nunes, C. A. (2022) · Amplla Editora eBooks · doi:10.51859/amplla.tis167.1122-3
A CÁRIE DENTÁRIA NAS POPULAÇÕES INDÍGENAS E SEUS DETERMINANTES SOCIAIS
Freitas, A. D. O., & de Almeida, M. E. L. (2022) · Amplla Editora eBooks · doi:10.51859/amplla.tis167.1122-4
EXERCÍCIOS FÍSICOS, INTERAÇÃO SOCIAL E MEMÓRIA EM IDOSOS SAUDÁVEIS
de Oliveira, A. L. B., Júnior, R. P. M., Aragão, G. F., & Macêdo, D. S. (2022) · Amplla Editora eBooks · doi:10.51859/amplla.tis167.1122-1
Diabetes Mellituslu Hastalarda Mikroalbuminüri ve D Vitamini
Karataş, S., Köse, Ş., & Hacıoğlu, Y. (2021) · DergiPark (Istanbul University)
COMPLEXOS DE RUTÊNIO, DOADORES DO ÓXIDO NÍTRICO, CANDIDATOS A NOVOS FÁRMACOS VASODILATADORES
Silva, A. P. G., Rocha, D. G., & Aragão, G. F. (2022) · Amplla Editora eBooks · doi:10.51859/amplla.tis167.1122-2
Cruz, M. D. A., Melo, A. C. F. L., & Aragão, G. F. (2022) · Amplla Editora eBooks · doi:10.51859/amplla.tis167.1122-8
“Incorporating a Gym Facility in a Lifestyle Medicine Practice for Patients with Diabetes Mellitus”
Nadolsky, K. Z., Baraki, A., & Nadolsky, S. (2022) · American Journal of Lifestyle Medicine · doi:10.1177/15598276221089898 · Cited by 3
Diagnosis, Classification, and Evaluation of Chronic Kidney Disease
Chen, T. K., & Grams, M. E. (2022) · Nephrology Self-Assessment Program · doi:10.1681/nsap.00022022
Cordero, M. T. A., Pérez, J. M. F., Benasuly, A. E. L., & Fernández, E. B. (2022) · Journal of MOVE and Therapeutic Science · doi:10.37382/jomts.v4i1.632
Plummer, E. S. (2022) · American Diabetes Association eBooks · doi:10.2337/9781580407700.ch06
Macrophages as a Target for Treating Diabetic Foot Ulcers
Zhu, L., Xiao, Y., Xiao, Y., Jiang, Y., Adama, M. P. R., & Gittes, G. K. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.106613
Ocular manifestations of systemic diseases
Schreiberová, Z., Pašková, B., Malušková, M., & Karhanová, M. (2022) · Medicína pro praxi · doi:10.36290/med.2022.041
1-Minute Pearls/Pitfalls for the Clinician
Dapaah-Afriyie, K., & Ting, M. H. (2022) · Journal of Brown Hospital Medicine · doi:10.56305/001c.38027
Look in or book in: The case for type 2 diabetes remission to prevent diabetic retinopathy
Cripps, J., & Cucuzzella, M. T. (2023) · Journal of Metabolic Health · doi:10.4102/jir.v6i1.79
The Impact of Statin Therapy on the Healing of Diabetic Foot Ulcers: A Retrospective Chart Review.Preprint
O’Dell, B., Rothenberg, G. M., Holmes, C., Priesand, S., Mizokami‐Stout, K., Brandt, E. J., & Schmidt, B. M. (2023) · Research Square · doi:10.21203/rs.3.rs-3084211/v1
Allam, M. M., Younan, M., Abdelhamid, M., Khan, M. A., Elshafee, M., & Nada, A. M. (2023) · Cardiovascular Endocrinology & Metabolism · doi:10.1097/xce.0000000000000295
Trends in anti-neuropathic medications turnover in Iraq
Al-Shammaa, Z. M., Aladul, M. I., & Essa, N. S. (2023) · Journal of Pharmaceutical Health Services Research · doi:10.1093/jphsr/rmad042
Iklé, J. M., Addala, A., & Maahs, D. M. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch69
A.Yu, K., Б.Б, Б., Urmanova, Y. М., & V.Sh, N. (2024) · Texas Journal of Medical Science · doi:10.62480/tjms.2024.vol29.pp43-50
Su, J., Guo, Y., Hu, J., Peng, J., Dong, Z., Xu, Z., Yu, X., Mei, J., Wang, L., Zhang, X., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3936711/v1
Wang, Y., Han, M., Li, Y.-T., Wang, Z., & Liu, J. (2022) · Figshare · doi:10.6084/m9.figshare.21383084
Prawiroharjo, P., Anggraini, H., Geraldi, I. P., Octaviana, F., Budikayanti, A., Safri, A. Y., Wiratman, W., Indrawati, L. A., Fadli, N., Harsono, A. R., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30713 · Cited by 1
Zhang, C., Duan, Z.-Y., Nie, S.-S., Zhang, Z., Guo, X.-R., Zhang, C., Dong, J., & Cai, G. (2024) · World Journal of Clinical Cases · doi:10.12998/wjcc.v12.i17.3061
Overview of Cellular Therapy: Reshaping the Wound in Diabetic Foot Ulcer
Fathima, M., & Jha, D. K. (2024) · Current Journal of Applied Science and Technology · doi:10.9734/cjast/2024/v43i74403
Diabetic peripheral arterial disease in COVID-19 pandemic
Ekim, M., Ekim, H., & Akarsu, G. D. (2024) · Journal of Research in Medical Sciences · doi:10.4103/jrms.jrms_509_23
Kanthed, P., Barasker, S. K., & Ravikumar, C. M. (2024) · Indian Journal of Pain · doi:10.4103/ijpn.ijpn_119_23
Attainment of LDL-cholesterol target in high cardiovascular risk type 1 diabetic French people
Breuker, C., Macioce, V., Lasse, A., Zogheib, M.-L., Cavallin, L., Herman, F., Picot, M., Gourdy, P., Sallerin, B., Avignon, A., et al. (2024) · Diabetes & Metabolism · doi:10.1016/j.diabet.2024.101568
Zhang, Z., Ji, M., Zhao, Q., Jiang, L., Fan, S., & Zuo, H. (2024) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2024.200347
Yadav, S. N., Adhikari, P., Koirala, S. R., Yadav, D., & Gautam, M. P. (2024) · International Journal of Innovative Science and Research Technology (IJISRT) · doi:10.38124/ijisrt/ijisrt24oct1438
(2022) · American Diabetes Association eBooks · doi:10.2337/9781580407700.ch03
Song, X., Yang, X., Liu, Q., Bian, X., Gao, L., & Tao, J. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s502475
The rate of progression of diabetic kidney disease in patients with type 1 diabetes mellitus
Bučková, L., Horackova, M., Hoffmann, P., Lustigová, M., Tothová, M., Koželuhová, M., Pátek, O., & Brož, J. (2025) · Vnitřní lékařství · doi:10.36290/vnl.2025.024
Bolakale‐Rufai, I. K., French, S. R., Knapp, S. M., Thompson, M., Arias, J. C., Garcia‐Filion, P., Ainapurapu, B., Tan, T., & Weinkauf, C. C. (2025) · Diabetology · doi:10.3390/diabetology6040024
Phan, H. H., Tran, H. D., Nguyen, H. T. T., Nguyễn, T. T., Pham, H. T. B., Bach, T. C. T., Pham, L. T. M., Lam, H. V., & Đậu, L. N. (2025) · Nursing Forum · doi:10.1155/nuf/4668927
Gao, X., Li, H., Diao, J., Liu, D., Sun, W., & Zhou, Z. C. (2025) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2025.12927
Wang, B., Li, H., Wang, L., & Chen, Z. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1622460
Hilmawati, F., & Karuniawati, H. (2025) · Journal of Pharmaceutical And Sciences · doi:10.36490/journal-jps.com.v8i3.1008
Han, Y.-N., Wang, T., Lin, Q., Li, C., & Ren, Y. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1662140
Metformin interferes with urinary creatinine measurement using enzymatic method
Yoshimoto, A., Morita, Y., Kume, Y., Yoshikawa, N., Ono, Y., Kurano, M., Yatomi, Y., & Ohkawa, R. (2025) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.102264 · Cited by 1
Yulia, R., Pusparisa, H., Hasan, F. A., & Herawati, F. (2025) · Journal of Advanced Pharmaceutical Technology amp Research · doi:10.4103/japtr.japtr_277_24
Chen, J., Wu, M., Wen, Q., Yuan, M., Liu, X., Zhang, M., & He, J. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s548145
Chang, Y.-S., Li, Y.-H., & Lee, I.-T. (2021) · Figshare · doi:10.6084/m9.figshare.16829266
Kato, S., Kuwatsuka, Y., Ando, M., Tatematsu, Y., Nishibori, N., & Maruyama, S. (2023) · Figshare · doi:10.6084/m9.figshare.23849510
Wang, Y., Han, M., Li, Y., Wang, Z., & Liu, J.-P. (2022) · Figshare · doi:10.6084/m9.figshare.21383078
O’Dell, B., Rothenberg, G. M., Holmes, C., Priesand, S., Mizokami‐Stout, K., Brandt, E. J., & Schmidt, B. M. (2024) · Figshare · doi:10.6084/m9.figshare.26690938
Wang, Y., Han, M., Li, Y., Wang, Z., & Liu, J.-P. (2022) · Figshare · doi:10.6084/m9.figshare.21383081
Montone, R. A., Pitocco, D., Gurgoglione, F. L., Rinaldi, R., Del Buono, M. G., Camilli, M., Rizzi, A., Tartaglione, L., Rizzo, G. E., Leo, M. A. S. D., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21343043
Kato, S., Kuwatsuka, Y., Ando, M., Tatematsu, Y., Nishibori, N., & Maruyama, S. (2023) · Figshare · doi:10.6084/m9.figshare.23849513
Utaminingsih, E., OKTASARI, S. R., & Cholisoh, Z. (2025) · Journal of Pharmaceutical And Sciences · doi:10.36490/journal-jps.com.v8i4.1123
Chen, X., He, W., Liu, D., Jia, R., Zhu, Y., Hou, H., Zhao, X., Wan, Q., & Wang, W. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1599024
Wu, R., Yang, X., Zhou, X., Xiao, Z., Chen, X., Zhou, J., Li, J., Yin, Z., Lai, X., Wang, T., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1733840
Srivastava, A., Jain, A., Patra, J., & Keshari, A. K. (2026) · Biointerface Research in Applied Chemistry · doi:10.33263/briac161.005
Dai, Y., Liu, L., Guo, X., Ye, P., He, W., Gu, R., Zhao, J., Zhang, Q., Tang, M., & Nie, X. (2026) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2026.02.017 · Cited by 1
Plasma R-spondin 2 levels are associated with the progression of diabetic kidney disease
Wang, Y., Chen, W., Xiong, X., Zhu, J., He, Q., Zhang, L., Qu, H., Zheng, H., & Zheng, Y. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1787296
Wu, Z.-Y., Ji, L., Tang, W., Zhou, S.-J., Yan, Q., Chen, X.-M., Zhu, J., Ma, J., Zhao, Y., & He, W. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-05660-9
Tian, Q., Zhang, Y., Cao, Q., Liu, Y., Ou, X., Zeng, Z., & Xu, L. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1767310
Shan, H., & Cao, J. (2026) · Clinical and Experimental Optometry · doi:10.1080/08164622.2026.2652027
Alqutub, S. T. (2026) · Preventive Medicine Research & Reviews · doi:10.4103/pmrr.pmrr_256_25
Li, Z., Wang, A., Wang, R., Cao, Y., Tao, Z., Sun, Z., Lin, Z., Cao, X., Yu, J., Zheng, X., et al. (2026) · Advances in Wound Care · doi:10.1177/21621918261455459
Yang, D., Jiang, H., Meng, M., Wang, Z., Shen, W., Liu, H., Yang, H., Li, X., & Hao, Y. (2026) · Journal of Diabetes Research · doi:10.1155/jdr/2842572
Teleretinal Imaging Enhances Equity in Diabetic Eye Screening at Urban Community Health Clinics
Khoussine, J., Peterson, K., Fowlkes, C., Maldonado, C., Hoang, J., Emmet, T., Pinzon, M. M., Garcia, D., Anaya, Y. B.-M., Channa, R., et al. (2026) · Telemedicine Journal and e-Health · doi:10.1177/15305627261477819
Jia, Y., Liu, S., Xu, T., Cao, X., Shen, L., & Tang, M. (2026) · Endocrine Research · doi:10.1080/07435800.2026.2727501
Homocysteine and mitophagy in diabetic retinopathy: unraveling the underlying molecular crosstalk
Tan, N., Chen, Y., Li, M., Liu, W., Li, X., Li, P., & 雷迅文 (2026) · Endocrine · doi:10.1007/s12020-026-04787-1
Riaz, N., Yasmeen, G., & Khan, M. A. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-026-02531-4
Ballesta, S., Pedro‐Botet, J., Climent, E., Fernández‐Veledo, S., Gaja, R., Garrido, A., Vendrell, J. J., Sánchez, J., Fernández-Miró, M., Chillarón, J. J., et al. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag422
Saleem, M., Khan, F. H., Almarshedy, S. M., Alenazi, F. S., Alshetaiwi, H., Ahmad, I., Alrashid, F. F., Ilyas, S. M. O., Almuwaisa, A. M., Alnomasi, W. N., et al. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1882663
Liu, Y., Zhao, Y., Wu, F., Zhu, Y., & Liu, C. (2026) · Assay and Drug Development Technologies · doi:10.1177/1540658x261496344
Metadata
- Authors
- American Diabetes Association
- Corresponding author
- American Diabetes Association
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2020-12-04
- Volume
- 44
- Issue
- Supplement_1
- Pages
- S151-S167
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W4230007976
- Cited by
- 395
- References
- 189
- Citations by year
- 2026: 23 · 2025: 44 · 2024: 66 · 2023: 70 · 2022: 124 · 2021: 68
- FWCI
- 10.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Dermatology › Skin Diseases and Diabetes
- Keywords
- microvascular complications, diabetic foot care, diabetes mellitus, clinical guidelines, diabetic foot ulcer, diabetic retinopathy, diabetic nephropathy, diabetic neuropathy
- MeSH terms
- Diabetes Mellitus, Endocrinology, Humans, Reference Standards, Societies, Medical, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
